SCHEMBL17620173

SCHEMBL17620173

O=C(OCC1O[C@H](Br)C(OC(=O)c2ccccc2)[C@@H](OC(=O)c2ccccc2)[C@H]1OC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 2/20 0.54
POLB P06746 2/20 0.54
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
PTPN1 P18031 4/20 0.49
PTPN2 P17706 1/20 0.46
PTPN11 Q06124 1/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA9 Q16790 1/20 0.46
TSHR P16473 1/20 0.46
ALDH1A1 P00352 1/20 0.45
F11 P03951 2/20 0.45
MAPK1 P28482 2/20 0.45
TMPRSS2 O15393 1/20 0.45
PDE5A O76074 1/20 0.45
HMGCR P04035 1/20 0.45
CYP1A2 P05177 1/20 0.45
LCK P06239 1/20 0.45
FYN P06241 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1726977 1.00 USP2 (0.54) USP2POLBMEN1KMT2APTPN1
SCHEMBL17620221 1.00 USP2 (0.54) USP2POLBMEN1KMT2APTPN1
SCHEMBL17620209 1.00 USP2 (0.54) USP2POLBMEN1KMT2APTPN1
SCHEMBL3663518 1.00 USP2 (0.54) USP2POLBMEN1KMT2APTPN1
SCHEMBL1728378 1.00 USP2 (0.54) USP2POLBMEN1KMT2APTPN1
SCHEMBL3272584 1.00 USP2 (0.54) USP2POLBMEN1KMT2APTPN1
SCHEMBL6022376 1.00 USP2 (0.54) USP2POLBMEN1KMT2APTPN1
SCHEMBL3663517 1.00 USP2 (0.54) USP2POLBMEN1KMT2APTPN1
SCHEMBL14103187 1.00 USP2 (0.54) USP2POLBMEN1KMT2APTPN1
SCHEMBL2493929 0.99 USP2 (0.55) USP2POLBMEN1KMT2APTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016041195-A1 FLAVONE GLYCOSIDE DERIVATIVES AND PREPARATION METHOD AND USE THEREOF 贵州百灵企业集团制药股份有限公司 2016-03-24 WO disclosed